2014-2018 European Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies. The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. Research Beam Model: Research Beam Product ID: 174798 2850 USD New
2014-2018 European Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

2014-2018 European Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies

 
  • Category : Diagnostic and Biotech
  • Published On : November  2014
  • Pages : 495
 
 

2014-2018 European Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies.



The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.



This new five-country study from Venture Planning Group contains 495 pages, 28 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.